385 related articles for article (PubMed ID: 1940124)
1. Dose-response study of vigabatrin in children with refractory epilepsy.
Herranz JL; Arteaga R; Farr IN; Valdizan E; Beaumont D; Armijo JA
J Child Neurol; 1991; Suppl 2():S45-51. PubMed ID: 1940124
[TBL] [Abstract][Full Text] [Related]
2. Vigabatrin in pediatric epilepsy--an open study.
Uldall P; Alving J; Gram L; Beck S
J Child Neurol; 1991; Suppl 2():S38-44. PubMed ID: 1940123
[TBL] [Abstract][Full Text] [Related]
3. Vigabatrin in childhood epilepsy.
Dulac O; Chiron C; Luna D; Cusmai R; Pajot N; Beaumont D; Mondragon S
J Child Neurol; 1991; Suppl 2():S30-7. PubMed ID: 1940122
[TBL] [Abstract][Full Text] [Related]
4. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
[TBL] [Abstract][Full Text] [Related]
5. [New drugs in the treatment of childhood epilepsy: vigabatrin (study of 61 subjects)].
Raucci U; Spalice A; Basile LA; Guardalà C; Nasta L; Terenzi S; Iannetti P
Pediatr Med Chir; 1994; 16(6):575-8. PubMed ID: 7708543
[TBL] [Abstract][Full Text] [Related]
6. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
Shinnar S; Pellock JM; Conry JA
Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
[TBL] [Abstract][Full Text] [Related]
7. The role of vigabatrin in the management of infantile epileptic syndromes.
Appleton RE
Neurology; 1993 Nov; 43(11 Suppl 5):S21-3. PubMed ID: 8232983
[TBL] [Abstract][Full Text] [Related]
8. Vigabatrin in pediatric patients with refractory epilepsy.
Turanli G; Celebi A; Yalnizoğlu D; Topçu M; Topaloğlu H; Banu A; Aysun S
Turk J Pediatr; 2006; 48(1):25-30. PubMed ID: 16562782
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and EEG/ERP brain mapping studies with vigabatrin in therapy refractory epileptic patients].
Pfersmann D; Saletu B; Semlitsch HV; Anderer P; Dieterich HA
Wien Med Wochenschr; 1993; 143(6):119-28. PubMed ID: 8517061
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of adjunctive therapy with zonisamide in childhood intractable epilepsy.
Lee YJ; Kang HC; Seo JH; Lee JS; Kim HD
Brain Dev; 2010 Mar; 32(3):208-12. PubMed ID: 19304420
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience.
Kluger G; Kurlemann G; Haberlandt E; Ernst JP; Runge U; Schneider F; Makowski C; Boor R; Bast T
Epilepsy Behav; 2009 Mar; 14(3):491-5. PubMed ID: 19162229
[TBL] [Abstract][Full Text] [Related]
12. Antiepileptic efficacy of vigabatrin in people with severe epilepsy and intellectual disability.
Ylinen A
J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():46-9. PubMed ID: 10030432
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic trial of vigabatrin in refractory infantile spasms.
Chiron C; Dulac O; Beaumont D; Palacios L; Pajot N; Mumford J
J Child Neurol; 1991; Suppl 2():S52-9. PubMed ID: 1940125
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
[TBL] [Abstract][Full Text] [Related]
15. Gamma-vinyl GABA (vigabatrin): clinical experience in adult and adolescent patients with intractable epilepsy.
Reynolds EH
Epilepsia; 1992; 33 Suppl 5():S30-4; discussion S34-5. PubMed ID: 1425498
[TBL] [Abstract][Full Text] [Related]
16. [Vigabatrin in childhood epilepsy--personal experience].
Zubcević S; Gavranović M; Catibusić F; Uzicanin S; Buljina A
Med Arh; 1999; 53(3 Suppl 2):63-5. PubMed ID: 10758766
[TBL] [Abstract][Full Text] [Related]
17. Treatment of pediatric epilepsies with gamma-vinyl GABA (vigabatrin).
Gram L; Sabers A; Dulac O
Epilepsia; 1992; 33 Suppl 5():S26-9. PubMed ID: 1425497
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
[TBL] [Abstract][Full Text] [Related]
19. Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study.
Coppola G; Grosso S; Verrotti A; Parisi P; Luchetti A; Franzoni E; Mangano S; Pelliccia A; Operto FF; Iannetti P; Curatolo P; Balestri P; Pascotto A
Epilepsy Res; 2009 Feb; 83(2-3):112-6. PubMed ID: 19081227
[TBL] [Abstract][Full Text] [Related]
20. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB
Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
